Showing results (201-210 of 352) with videos related to

Sort By:
Pageof 36
Journal of Hepatology|June 27, 2012
A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI)David J Pinato, Justin Stebbing, Mitsuru Ishizuka, et al.
International Journal of Cancer|December 30, 2003
The efficacy of ritonavir in the prevention of AIDS-related Kaposi's sarcomaJustin Stebbing, Simon Portsmouth, Mark Nelson, et al.
Pharmacogenomics|December 24, 2008
Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patientsRachel E Payne, Ernesto Yagüe, Martin J Slade, et al.
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Oncotargets and Therapy|June 3, 2021
Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLCLing Peng, Kui Xiao, Jian Cui, et al.
Breast Cancer Research and Treatment|April 6, 2024
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT studyRebecca C Allsopp, Qi Guo, Karen Page, et al.
Biomarkers in Medicine|February 16, 2011
Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancerJacqui A Shaw, James Brown, R Charles Coombes, et al.
Blood|July 9, 2004
Protease inhibitors potentiate chemotherapy-induced neutropeniaMark Bower, Neil McCall-Peat, Natalie Ryan, et al.
The Journal of Antimicrobial Chemotherapy|December 21, 2004
A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study)Chloe Orkin, Justin Stebbing, Mark Nelson, et al.
Epigenomics|July 31, 2013
The p53 miRNA interactome and its potential role in the cancer clinicJonathan Krell, Adam E Frampton, Teresa Colombo, et al.
Pageof 36